Aller au contenu principal
Accès ouvert déclaré 2025 article

Practice Patterns and Outcomes in Advanced Colorectal Cancers From a Multi-Institutional Analysis: Real-World Evidence From India

0Citations signalées — pas une note de qualité
17Institutions déclarées
3Pays d’affiliation déclarés

Résumé fourni par la source

PURPOSE There are limited data on presentation and practice patterns, survival, and factors influencing overall survival (OS) in Indian patients with metastatic colorectal cancers (mCRCs). PATIENTS AND METHODS The current study evaluated patients from 13 institutions across India diagnosed with mCRC and treated from January 2016 to May 2022. The primary end point of the study was the estimation of median OS by the Kaplan-Meier method. RESULTS The data of 3,009 patients were submitted, of whom 2,520 were feasible for analysis. Molecular testing for rat sarcoma virus and/or B-Rapidly Accelerated Fibrosarcoma status via the polymerase chain reaction or next-generation sequencing was conducted in 993 patients (39%). At a median follow-up of 44.6 months (95% CI, 40.8 to 48.3), the median OS for the entire cohort was 18.7 months (95% CI, 18.0 to 19.4). The presence of signet ring (SR) histology (14.65 v 19.15 months, hazard ratio [HR] 1.30 [95% CI, 1.14 to 1.48]; P < .001) and Eastern Cooperative Oncology Group performance status (ECOG PS) 2 versus ECOG PS 0 or 1 (18.0 v 22.87 months, HR 1.37 [95% CI, 1.21 to 1.55]; P < .001) predicted inferior OS, whereas the receipt of monoclonal antibodies (MAbs; 21.81 v 16.92 months, HR 0.79 [95% CI, 0.72 to 0.87]; P < .001) and exposure to greater than two lines of therapy (26.71 v 16.26 months, HR 0.56 [95% CI, 0.50 to 0.62]; P < .001) were associated with improved OS. CONCLUSION The current multi-institutional analysis of more than 2,500 patients with mCRC in India establishes a baseline with regard to clinicopathologic characteristics, molecular testing patterns, and survival. It recognizes the importance of impaired ECOG PS, SR histology, exposure to MAbs, and multiple lines of systemic therapeutic options as factors influencing OS.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.

Contrôle bibliographique ouvert

DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.

Titre Crossref
Practice Patterns and Outcomes in Advanced Colorectal Cancers From a Multi-Institutional Analysis: Real-World Evidence From India
Date Crossref
01/11/2025
Éditeur
American Society of Clinical Oncology (ASCO)
Type
journal-article

Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude et ne compte pas comme une seconde source scientifique indépendante.

Institutions déclarées

Une affiliation ne permet pas de déduire la nationalité d’un auteur.

Sujets associés

Colorectal Cancer Treatments and StudiesColorectal Cancer Surgical TreatmentsGenetic factors in colorectal cancer

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.